Elanco Animal Health Incorporated
ELAN
$13.33
-$0.28-2.06%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 373.00M | 338.00M | 205.00M | -1.26B | -1.30B |
| Total Depreciation and Amortization | 617.00M | 622.00M | 615.00M | 618.00M | 633.00M |
| Total Amortization of Deferred Charges | 40.00M | 40.00M | 54.00M | 54.00M | 54.00M |
| Total Other Non-Cash Items | -584.00M | -608.00M | -592.00M | 1.12B | 1.07B |
| Change in Net Operating Assets | 89.00M | 149.00M | 239.00M | 18.00M | -38.00M |
| Cash from Operations | 535.00M | 541.00M | 521.00M | 557.00M | 418.00M |
| Capital Expenditure | -188.00M | -147.00M | -141.00M | -132.00M | -140.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -36.00M | -36.00M | 0.00 | -3.00M | -3.00M |
| Divestitures | 1.30B | 1.36B | 1.36B | 66.00M | 66.00M |
| Other Investing Activities | -16.00M | -19.00M | -6.00M | 2.00M | 0.00 |
| Cash from Investing | 1.06B | 1.16B | 1.21B | -67.00M | -77.00M |
| Total Debt Issued | 720.00M | 570.00M | 570.00M | 570.00M | 500.00M |
| Total Debt Repaid | -2.11B | -2.05B | -2.15B | -970.00M | -771.00M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -23.00M | -17.00M | -23.00M | -16.00M | -13.00M |
| Cash from Financing | -1.41B | -1.49B | -1.60B | -416.00M | -284.00M |
| Foreign Exchange rate Adjustments | -43.00M | -91.00M | -14.00M | -25.00M | -30.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 142.00M | 116.00M | 121.00M | 49.00M | 27.00M |